Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
Published: April 13, 2020
- The epidemic of type 2 diabetes mellitus (T2D), linked to the increased burden of obesity, is projected to affect over 600 million patients worldwide in the next 2 decades.
- While glycemic control has been recommended as a part of comprehensive risk factor management in patients with coronary artery disease (CAD), growing evidence suggests that how glucose is managed can have a substantial impact on cardiovascular outcomes.
- This scientific statement provides a comprehensive summary of effective, patient-centered management of CAD in patients with T2D with an emphasis on the emerging evidence that can directly improve clinical outcomes.
- Commentary: Optimizing Risk Factors and Management of Chronic Coronary Artery Disease in Patients with Type 2 Diabetes by Debabrata Mukherjee, MD, MS, FAHA
- Top Things to Know: Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
- News Release: People with type 2 diabetes and heart disease may benefit from newer therapies